BRIEF published on 06/01/2026 at 17:51, 25 days 20 hours ago HBM Healthcare Investments affiche des performances stables Performance Financière Valeur Nette D'actif Marché Suisse Investissements HBM Dans Le Secteur De La Santé Croissance Du Cours De L'action
PRESS RELEASE published on 06/01/2026 at 17:46, 25 days 20 hours ago Key Figures 31.05.2026 HBM Healthcare Investments AG reports key figures for May 2026, showing NAV at 287.92 CHF with a 2.5% CYTD performance. Share price at 238.00 CHF with 5.1% performance CYTD Financial Performance HBM Healthcare Investments AG Key Figures CHF May 2026
BRIEF published on 06/01/2026 at 08:38, 26 days 5 hours ago HBM Healthcare finalise l'acquisition de Swixx Biopharma Bain Capital Swixx BioPharma HBM Healthcare Croissance Biopharmaceutique SK CAPITAL
BRIEF published on 06/01/2026 at 08:38, 26 days 5 hours ago HBM Healthcare Completes Swixx Biopharma Transaction Bain Capital Swixx BioPharma HBM Healthcare Biopharmaceutical Growth SK CAPITAL
PRESS RELEASE published on 06/01/2026 at 08:33, 26 days 5 hours ago HBM Healthcare Investments Announces Closing of Swixx Biopharma Transaction with SK Capital and Bain Capital Life Sciences HBM Healthcare Investments successfully closes Swixx Biopharma transaction with SK Capital and Bain Capital Life Sciences, remaining a significant shareholder Acquisition HBM Healthcare Investments Swixx BioPharma SK CAPITAL Bain Capital Life Sciences
BRIEF published on 05/26/2026 at 13:15, 1 month 1 day ago Eli Lilly to Acquire Curevo Vaccine for Up to USD 1.5 Billion Biotechnology HBM Healthcare Eli Lilly Acquisition Curevo Vaccine Shingles Prevention
BRIEF published on 05/26/2026 at 13:15, 1 month 1 day ago Eli Lilly va acquérir le vaccin Curevo pour un montant pouvant atteindre 1,5 milliard de dollars américains. Biotechnologie HBM Healthcare Acquisition D'Eli Lilly Vaccin Curevo Prévention Du Zona
PRESS RELEASE published on 05/26/2026 at 13:10, 1 month 1 day ago Eli Lilly to Acquire HBM Portfolio Company Curevo for up to USD 1.5 Billion Eli Lilly to acquire HBM portfolio company Curevo for up to USD 1.5 billion, boosting HBM Healthcare Investments' net asset value. Curevo focuses on developing vaccines for infectious diseases Acquisition HBM Healthcare Investments Eli Lilly Vaccines Curevo
BRIEF published on 05/18/2026 at 17:52, 1 month 8 days ago HBM Healthcare Investments AG Releases Key Figures for May 2026 Financial Performance Net Asset Value Share Price Investment Risks HBM Healthcare
BRIEF published on 05/18/2026 at 17:52, 1 month 8 days ago HBM Healthcare Investments AG publie ses principaux chiffres pour mai 2026 Performance Financière Valeur Nette D'actif Prix De L'action Risques D'investissement HBM Healthcare
Published on 06/27/2026 at 01:40, 12 hours 40 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 14 hours 20 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 15 hours 20 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 15 hours 30 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 16 hours 5 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 14 hours 15 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 14 hours 16 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 14 hours 44 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 14 hours 44 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 14 hours 52 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 20 hours 35 minutes ago Descriptif du programme de rachat d'actions
